Cargando…
Potential Clinical and Economic Impact of Switching Branded Medications to Generics
Switching branded to generic medications has become a common cost-containment measure. Although this is an important objective for health care systems worldwide, the impact of this practice on patient outcomes needs to be carefully considered. We reviewed the literature summarizing the potential cli...
Autores principales: | Straka, Robert J., Keohane, Denis J., Liu, Larry Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal of Therapeutics
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417581/ https://www.ncbi.nlm.nih.gov/pubmed/26099048 http://dx.doi.org/10.1097/MJT.0000000000000282 |
Ejemplares similares
-
Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
por: Desai, Rishi J, et al.
Publicado: (2018) -
Brand and generic medications: Are they interchangeable?
por: Al-Jazairi, Abdulrazaq S., et al.
Publicado: (2008) -
Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2017) -
Recurrence of atrial fibrillation after switching from brand to generic atenolol
por: Gallelli, Luca, et al.
Publicado: (2015) -
Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia
por: Ordóñez, Karen, et al.
Publicado: (2019)